Is Preoperative Chemoprophylaxis Safe for Venous Thromboembolism Prevention in Patients With Head and Neck Cancer?
Otolaryngology–Head and Neck Surgery · 2024
DOI: 10.1002/ohn.875 ↗Kurz gefasst
Fachartikel in der Zeitschrift Otolaryngology–Head and Neck Surgery, 2024. Verfasst von Heba Isaac und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, University of Iowa Hospitals and Clinics, Iowa City, USA. Hauptthemen laut MEDLINE: Venous Thromboembolism, Head and Neck Neoplasms, Preoperative Care, Anticoagulants. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Thromboseprophylaxe
Abstract (Originalsprache)
Objective
To assess the safety of preoperative chemoprophylaxis (PEC) in head and neck cancer (HNC) patients undergoing oncologic procedures. Study Design Retrospective cohort study.
Setting
Tertiary academic center.
Methods
HNC patients with Caprini risk score (CRS) ≥5 who underwent inpatient surgery ≥3 hours between 2015 and 2020 were included. Patients were divided into 2 cohorts, PEC and control, based on whether or not they received a single dose of low molecular weight heparin or unfractionated heparin prior to surgery. The primary endpoint was the 30‐day rate of major bleeding events.
Results
A total of 539 patients were included; 427 patients received PEC prior to surgery. The rate of major bleeding was 6.7%. The PEC cohort was more likely to have received concurrent aspirin or ketorolac (225 of 427 patients vs 36 of 112 patients; P = .0002), greater duration of chemoprophylaxis (7.8 vs 5.0 days; P < .0001), have higher CRS (7.2 vs 6.6; P < .0001), longer operative times (596 vs 512 minutes; P < .0001), higher blood loss (265 vs 214 ml; P = .02), and higher bleeding rates when compared to the control (34 of 427 patients; P = .03). On multivariate analysis, only PEC was associated with bleeding (odds ratio, 8.74; 95% confidence interval, 1.15‐66.5). The rate of VTE was 1.3% and was not significantly different between cohorts.
Conclusion
PEC was associated with an increase in bleeding and did not result in lower rates of VTE in patients with HNC. This study highlights the need to determine the optimal regimen of chemoprophylaxis in this patient cohort. Level of Evidence 3
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otolaryngology-Head and Neck Surgery, University of Iowa Hospitals and Clinics, Iowa City, USA.
- Department of Otolaryngology, SUNY Upstate, Syracuse, USA.
Zitieren
APA
Isaac, H., Arnold, M. A., Pagedar, N. A., Buchakjian, M. R., & Arnold, K. E. (2024). Is Preoperative Chemoprophylaxis Safe for Venous Thromboembolism Prevention in Patients With Head and Neck Cancer?. Otolaryngology–Head and Neck Surgery. https://doi.org/10.1002/ohn.875
Vancouver
Isaac H, Arnold MA, Pagedar NA, Buchakjian MR, Arnold KE. Is Preoperative Chemoprophylaxis Safe for Venous Thromboembolism Prevention in Patients With Head and Neck Cancer?. Otolaryngology–Head and Neck Surgery. 2024. doi:10.1002/ohn.875
BibTeX
@article{Isaac2024,
author = {Isaac, Heba and Arnold, Mark A and Pagedar, Nitin A and Buchakjian, Marisa R and Arnold, Kiranya E},
title = {Is Preoperative Chemoprophylaxis Safe for Venous Thromboembolism Prevention in Patients With Head and Neck Cancer?},
journal = {Otolaryngology–Head and Neck Surgery},
year = {2024},
doi = {10.1002/ohn.875}
}
EUVIMED